Early real-world data suggest that weekly at-home subcutaneous lecanemab may offer a feasible alternative to ongoing IV maintenance treatment for early Alzheimer’s disease.
Infants who do not receive intramuscular vitamin K prophylaxis at birth have higher odds of bleeding episodes and intracranial hemorrhage during the first 6 months of life.
Rapid weight loss with GLP-1 drugs is changing aesthetic practice, as surgeons address facial volume loss, excess skin, and ...
Breast, colon, and cervical cancer incidence and mortality have improved for First Nations patients, but survival is ...
In two studies in retinal disease, faricimab shows improved vision and a reduced injection burden in people who switched from ...
As patents expire, generic injectable semaglutide could become available at a fraction of current branded prices — around $28-$140 per person-year — in about 162 countries by the end of 2026.
Following bariatric surgery, women with food addiction report a higher intake of ultraprocessed foods, greater anxiety, lower ...
A Medscape commentary asks whether older physicians should be tested for competence. Readers answer with a question of their own: Why single out age?
People with sickle cell disease received immediate postpartum long-acting reversible contraception at more than three times ...
Gradually spacing belimumab doses appears feasible in patients with prolonged remission from systemic lupus erythematosus, ...
A multidisciplinary group of experts has issued recommendations for managing systemic cancer therapies in patients undergoing ...
Among Black children, percent African ancestry is associated with an increased risk for asthma and allergen-specific sensitization.